Alastin Skincare, Inc.—a specialty aesthetics company dedicated to developing and marketing clinically tested, physician-dispensed skin care products—has announced that the United States Patent and Trademark Office has issued a fourth U.S. Patent, No. 10,688,147, incorporating Alastin's platform TriHex Technology. The patent is directed to a topical composition for alleviating bruising caused by a cosmetic procedure—INhance Post-Injection Serum with TriHex Technology.
Read more at PR Newswire >>